- Report
- May 2024
- 550 Pages
Global
From €3839EUR$3,995USD£3,282GBP
- Report
- May 2024
- 350 Pages
Global
From €3839EUR$3,995USD£3,282GBP
- Report
- February 2024
- 175 Pages
Global
From €3843EUR$4,000USD£3,286GBP
- Report
- January 2024
- 106 Pages
Global
€4799EUR$4,995USD£4,103GBP
- Report
- April 2022
- 400 Pages
Global
€1681EUR$1,750USD£1,438GBP
- Report
- October 2021
- 433 Pages
Global
From €2250EUR$2,508USD£1,991GBP
- Report
- July 2021
- 259 Pages
Global
From €2150EUR$2,397USD£1,902GBP
- Report
- May 2018
- 140 Pages
Global
From €3363EUR$3,500USD£2,875GBP
The Antibody Technology market is a subset of the larger Biotechnology industry. It focuses on the development and production of antibodies, which are proteins used to identify and neutralize foreign substances in the body. Antibodies are used in a variety of medical treatments, including cancer, autoimmune diseases, and infectious diseases. They are also used in research and diagnostics.
The Antibody Technology market is highly competitive, with many companies offering a range of products and services. Companies in the market specialize in the production of antibodies, antibody engineering, antibody discovery, and antibody-based therapeutics. They also provide services such as antibody production, antibody engineering, and antibody-based diagnostics.
Some of the major companies in the Antibody Technology market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, Genentech, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more